Target haemoglobin concentrations in chronic kidney disease

Affiliations

¹ Harvard Medical School, Massachusetts General Hospital, and the New England Journal of Medicine, Boston, MA, USA.
² Department of Medicine and Transplantation, Ospedali Riuniti di Bergamo, and Mario Negri Institute for Pharmacological Research, Bergamo, Italy. Electronic address: gremuzzi@marionegri.it.

Comment

Julie R Ingelfinger et al. Lancet. 2007.

. 2007 May 5;369(9572):1515.

doi: 10.1016/S0140-6736(07)60700-4.

¹ Harvard Medical School, Massachusetts General Hospital, and the New England Journal of Medicine, Boston, MA, USA.
² Department of Medicine and Transplantation, Ospedali Riuniti di Bergamo, and Mario Negri Institute for Pharmacological Research, Bergamo, Italy. Electronic address: gremuzzi@marionegri.it.

No abstract available

Comment on

Haemoglobin targets: we were wrong, time to move on.
Strippoli GF, Tognoni G, Navaneethan SD, Nicolucci A, Craig JC. Strippoli GF, et al. Lancet. 2007 Feb 3;369(9559):346-50. doi: 10.1016/S0140-6736(07)60165-2. Lancet. 2007. PMID: 17276756 No abstract available.
Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
Phrommintikul A, Haas SJ, Elsik M, Krum H. Phrommintikul A, et al. Lancet. 2007 Feb 3;369(9559):381-8. doi: 10.1016/S0140-6736(07)60194-9. Lancet. 2007. PMID: 17276778